Inventor · disambiguated record
Lorenz Mayr
Also filed as: MAYR LORENZ · MAYR LORENZ M · MAYR LORENZ MARTIN
6 granted patents·5 pending applications·13 citations·filing 1999–2024
76Inventor score
Top patents by PatentIndex Score
11 records- 0186US10465011B2Factor XI antibodies and methods of useNOVARTIS AG·Filed 2016·Granted Nov 5, 2019·5 cites·16 claims
- 0276US10947559B2Inducible modification of a cell genomeASTRAZENECA AB·Filed 2016·Granted Mar 16, 2021·2 cites·23 claims
- 0373US8053457B23-imidazolyl-indoles for the treatment of proliferative diseasesNOVARTIS AG·Filed 2008·Granted Nov 8, 2011·3 cites·11 claims
- 0471US2024067750A1Factor xi antibodies and methods of useNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0568US2025034562A1Compositions and methods for improving the efficacy of cas9-based knock-in strategiesASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0662US12509702B2Inducible modification of a cell genomeASTRAZENECA AB·Filed 2021·Granted Dec 30, 2025·0 cites·9 claims
- 0760US2020115468A1Factor xi antibodies and methods of useNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0848US2021180059A1Compositions and methods for improving the efficacy of cas9-based knock-in strategiesASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 0945US2020370056A1Cell lines and methods for increased protein productionASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 1039US11254928B2Gene modification assaysASTRAZENECA AB·Filed 2017·Granted Feb 22, 2022·0 cites·20 claims
- 1137US6900194B1Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseasesBAYER AG·Filed 1999·Granted May 31, 2005·3 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →